Literature DB >> 15522932

The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance.

Catherine W Yeckel1, Sara E Taksali, James Dziura, Ram Weiss, Tania S Burgert, Robert S Sherwin, William V Tamborlane, Sonia Caprio.   

Abstract

Normal glucose tolerance is expressed over a wide range of glucose concentrations. Whether there is a continuum of risk for developing type 2 diabetes mellitus even when the 2-h plasma glucose is still within this normal range is uncertain. Oral glucose tolerance tests were performed in 407 obese normal glucose tolerance youth (4-20 yr) to examine the relationship between variations in 2-h plasma glucose levels and beta-cell responsiveness. Individuals were grouped by 2-h plasma glucose levels as follows: 1) less than 100 mg/dl, 2) 100-119 mg/dl, and 3) 120-139 mg/dl. Subsequent analysis stratified each 2-h plasma level by insulin sensitivity index. Increased 2-h glucose level was associated with a progressive increase in glucose between 0 and 30 min (P < 0.05). The Delta (0-30 min) insulin did not vary significantly across levels, thus resulting in a decreased insulinogenic index (P < 0.02). This pattern was observed at every level of insulin sensitivity (P < 0.02). These data translated to an unfavorable (leftward) shift in the insulin feedback system for increasing 2-h glucose level (P < 0.005). Increased 2-h plasma glucose within the range of normal glucose tolerance in obese youth is associated with a specific impairment of beta-cell responsiveness distinct from the deterioration of insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522932     DOI: 10.1210/jc.2004-1258

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  34 in total

1.  To: Godsland IF, Jeffs JA, Johnston DG (2004) loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157-1166.

Authors:  M A Abdul-Ghani; R A DeFronzo
Journal:  Diabetologia       Date:  2005-08-17       Impact factor: 10.122

Review 2.  Development of type 2 diabetes in children and adolescents.

Authors:  Ram Weiss; Sara E Taksali; Sonia Caprio
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

3.  Fructose Consumption Contributes to Hyperinsulinemia in Adolescents With Obesity Through a GLP-1-Mediated Mechanism.

Authors:  Alfonso Galderisi; Cosimo Giannini; Michelle Van Name; Sonia Caprio
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

Review 4.  Type 2 diabetes mellitus in pediatrics: a new challenge.

Authors:  Michelle Van Name; Nicola Santoro
Journal:  World J Pediatr       Date:  2013-11-14       Impact factor: 2.764

Review 5.  Cardiometabolic risk in obese children.

Authors:  Stephanie T Chung; Anthony U Onuzuruike; Sheela N Magge
Journal:  Ann N Y Acad Sci       Date:  2018-01       Impact factor: 5.691

6.  High-Normal Adolescent Fasting Plasma Glucose Is Associated With Poorer Midlife Brain Health: Bogalusa Heart Study.

Authors:  Owen Carmichael; Patrick Stuchlik; Sreekrishna Pillai; Geert-Jan Biessels; Ram Dhullipudi; Anna Madden-Rusnak; Shane Martin; Daniel S Hsia; Vivian Fonseca; Lydia Bazzano
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 7.  Obesity in children and adolescents.

Authors:  Anna M G Cali; Sonia Caprio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

8.  One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study.

Authors:  Melania Manco; Simona Panunzi; David P Macfarlane; Alain Golay; Olle Melander; Thomas Konrad; John R Petrie; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2010-09       Impact factor: 19.112

9.  Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.

Authors:  Ebe D'Adamo; Anna M G Cali; Ram Weiss; Nicola Santoro; Bridget Pierpont; Veronika Northrup; Sonia Caprio
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 17.152

10.  A single-nucleotide polymorphism in a methylatable Foxa2 binding site of the G6PC2 promoter is associated with insulin secretion in vivo and increased promoter activity in vitro.

Authors:  Christine Dos Santos; Pierre Bougnères; Delphine Fradin
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.